Q3 2020 EPS Estimates for Aphria Inc Reduced by Seaport Global Securities (APHA)

Aphria Inc (NYSE:APHA) – Analysts at Seaport Global Securities decreased their Q3 2020 EPS estimates for shares of Aphria in a report issued on Monday, April 15th, according to Zacks Investment Research. Seaport Global Securities analyst B. Hundley now anticipates that the company will post earnings of $0.04 per share for the quarter, down from their previous forecast of $0.05. Seaport Global Securities currently has a “Buy” rating and a $18.00 price target on the stock. Seaport Global Securities also issued estimates for Aphria’s Q4 2020 earnings at $0.03 EPS and FY2021 earnings at $0.31 EPS.

A number of other research firms have also recently commented on APHA. ValuEngine upgraded Aphria from a “hold” rating to a “buy” rating in a research report on Monday, April 1st. Cormark set a $15.00 price objective on Aphria and gave the stock a “buy” rating in a research report on Saturday, February 2nd. Clarus Securities assumed coverage on Aphria in a research report on Tuesday, April 16th. They set a “buy” rating and a $22.75 price objective for the company. Zacks Investment Research cut Aphria from a “hold” rating to a “sell” rating in a research report on Friday, April 19th. Finally, CIBC assumed coverage on Aphria in a research report on Friday, January 18th. They set a “neutral” rating for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $15.69.

Aphria stock traded down $0.20 during midday trading on Wednesday, reaching $6.74. 2,884,679 shares of the company were exchanged, compared to its average volume of 6,426,573. The stock has a market cap of $1.70 billion, a PE ratio of 48.14 and a beta of 3.66. Aphria has a 1 year low of $3.75 and a 1 year high of $16.86.

Aphria (NYSE:APHA) last released its quarterly earnings results on Monday, April 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.11). The firm had revenue of $55.24 million during the quarter, compared to analyst estimates of $41.11 million.

Institutional investors and hedge funds have recently bought and sold shares of the business. Financial Advocates Investment Management purchased a new stake in Aphria in the 4th quarter valued at about $89,000. Winslow Evans & Crocker Inc. purchased a new stake in Aphria in the 4th quarter valued at about $28,000. Intercontinental Wealth Advisors LLC purchased a new stake in Aphria in the 4th quarter valued at about $28,000. Liberty Wealth Management LLC purchased a new stake in Aphria in the 4th quarter valued at about $35,000. Finally, Truvestments Capital LLC purchased a new stake in Aphria in the 1st quarter valued at about $61,000. Institutional investors own 10.71% of the company’s stock.

About Aphria

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

See Also: Index Funds

Get a free copy of the Zacks research report on Aphria (APHA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aphria (NYSE:APHA)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.